OBJECTIVE To calculate the costs at Kilifi District Hospital (KDH) and Malindi Sub-district Hospital (MSH) of treating paediatric malaria admissions including three common presentations of severe paediatric malaria, i.e. cerebral malaria, severe malaria anaemia and malaria-associated seizures ; and to estimate the implications for hospital expenditure of a reduction in paediatric malaria admissions.
METHODS Patient data were obtained from hospital records.
All costs were allocated to departments that provided direct patient care by a four-stage step-down procedure.
Laboratory and drug costs of treating paediatric malaria admissions were separately identified.
RESULT Unit recurrent costs per admission in KDH ranged from US $57 for'other'paediatric malaria to US $105 for cerebral malaria, and in MSH from US $33 to US $44 for the same categories.
The annual recurrent cost of treating all paediatric malaria admissions to KDH prior to the trial was estimated at US $78 900.
Adjusting for preintervention differences in malaria admission rates and age between intervention and control areas, the ITBN trial found a 41% reduction in paediatric malaria admissions.
The reduction in admissions resulted in an estimated saving of US $6240 in the cost of treating paediatric malaria admissions from the intervention area. (...)
Mots-clés Pascal : Paludisme, Protozoose, Parasitose, Infection, Enfant, Homme, Coût, Economie santé, Prévention, Résultat, Dépense, Insecticide, Lutte sanitaire, Kenya, Afrique, Moustiquaire
Mots-clés Pascal anglais : Malaria, Protozoal disease, Parasitosis, Infection, Child, Human, Costs, Health economy, Prevention, Result, Expenditure, Insecticide, Sanitary control, Kenya, Africa
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0195140
Code Inist : 002B05E02B4. Création : 11/09/1998.